Candida glabrata prosthesis infection following pyelonephritis and septicaemia

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 6, 1997, Pages 635-638

  Nayeri, Fariba ^a   Cameron, Robert ^a   Chryssanthou, Erja ^b   Johansson, Lars ^a   Söderström, Claes ^a  

^a KALMAR COUNTY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANDIDA GLABRATA; CANDIDIASIS; CASE REPORT; FEMALE; GRAFT INFECTION; HUMAN; PROSTHESIS FAILURE; PYELONEPHRITIS; RANDOM AMPLIFIED POLYMORPHIC DNA; SEPTICEMIA; TOTAL HIP PROSTHESIS;

EID: 0031432474     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709035912     Document Type: Article

References (16)

1. Valdivieso M, Luna M, Bodey GP, Rodriguez V, Gröschel D. Fungemia due to Torulopsis glabrata in the compromised host. Cancer 1976; 38: 1750-6.
2. Hahn H, Condie F, Bulger R. Diagnosis of Torulopsis glabrata infection. JAMA 1968; 203: 835-6.
3. Connolly J, Mitas J. Torulopsis glabrata fungemia in a diabetic patient. South Med J 1990; 83: 352-3.
4. Spinillo A, Nicola S, Colonna L, Marangoni E, Cavanna C, Michelone G. Frequency and significance of drug resistance in vulvovaginal candidiasis. Gynecol Obstet Invest 1994; 38: 130-3.
5. Brause BD. Prosthetic joint infections. Curr Opin Rheumatol 1989; 1: 194-8.
6. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Proposed standard M27-T. Villanova, PA: National Committee for Clinical Laboratory Standards 1995.
7. Caetano-Anolles G, Bassam BJ, Gresshoff PM. DNA amplification fingerprinting using very short arbitrary oligonucleotide primers. Biotechnology 1991; 9: 553-6.
8. Bostock A, Khattak MN, Matthews R, Burnie J. Comparison of PCR fingerprinting, by random amplification of polymorphic DNA, with other molecular typing methods for Candida Albicans. J Gen Microbiol 1993; 139: 2179-84.
9. Fitzgerald RH, Nolan DR, Ilstrup DM, Van Scoy RE. Washington JA, Coventry MB. Deep wound sepsis following total hip artheroplasty. J Bone Joint Surg 1993; 59: 847-55.
10. Edebo L, Spetz Å. Urinary tract infection with Torulopsis glabrata treated by alkalisation of urine. Br Med J 1965; 2: 983-4.
11. Wall I, Tiselius HG, Hellgren E. Minimally invasive treatment of hemiacidrin soluble staghorn renal stones. J Lithotripsi Stone Dis 1991; 3.
12. Hennessy MJ. Infection of total knee arthroplasty by Candida parapsiloisis. A case report of successful treatment by joint reimplantation with a literature review. Am J Knee Surg 1996; 9: 133 6.
13. Nishida T, Mayumi H, Kawachi Y, Tokunga S, Maruyama Y, Nakashima A, et al. The efficacy of fluconazole in treating prosthetic valve endocarditis caused by Candida glabrata: report of a case. Surg Today 1994; 24: 651-4.
14. Vanden Bossche H, Marichal P, Odds FC, Le Jeune L, Coene MC. Characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother 1992; 36: 2602-10.
15. Fitzgerald RH Jr, Jones DR. Hip implant infection. Treatment with resection arthroplasty and late total hip artheroplasty. Am J Med 1985; 78: 225-8.
16. O'Neill DA, Harris WH. Failed total hip replacement: Assessment by plain radiographs, arthrograms, and aspiration of the hip joint. J Bone Joint Surg 1984; 66: 540-6.